New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents
Patent
·
OSTI ID:870821
- Columbia, MO
A class of diagnostic and therapeutic compounds derived from phosphinimines that include ligands containing either a single phosphinimine functionality or both a phosphinimine group and a phosphine or arsine group, or an aminato group, or a second phosphinimine moiety. These phosphinimine ligands are complexed to early transition metal radionuclides (e.g. .sup.99m Tc or .sup.186 Re/.sup.188 Re) or late transition metals (e.g., .sup.105 Rh or .sup.109 Pd). The complexes with these metals .sup.186 Re/.sup.188 Re, .sup.99m Tc and .sup.109 Pd exhibit a high in vitro and high in vivo stability. The complexes are formed in high yields and can be neutral or charged. These ligands can also be used to form stable compounds with paramagnetic transition metals (e.g. Fe and Mn) for potential use as MRI contrast agents. Applications for the use of ligands and making the ligands are also disclosed.
- Research Organization:
- University of Missouri
- DOE Contract Number:
- FG02-89ER60875
- Assignee:
- Curators of University of Missouri (Columbia, MO)
- Patent Number(s):
- US 5601800
- OSTI ID:
- 870821
- Country of Publication:
- United States
- Language:
- English
Similar Records
New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents
Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents
Radiolabeling proteins with bifunctional chelating agents
Patent
·
1997
·
OSTI ID:441867
Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents
Patent
·
2004
·
OSTI ID:1174992
Radiolabeling proteins with bifunctional chelating agents
Thesis/Dissertation
·
1991
·
OSTI ID:7165643
Related Subjects
/424/999/
105
109
186
188
99m
agents
aminato
applications
arsine
charged
complexed
complexes
compounds
containing
contrast
contrast agent
contrast agents
derived
design
diagnostic
diagnostic radiopharmaceutical
disclosed
exhibit
form
form stable
formed
functionality
imaging
imaging agent
imaging agents
ligands
metal
metals
mn
moiety
mri
multifunctional
multifunctional ligand
neutral
paramagnetic
pd
phosphine
phosphinimine
phosphinimines
potential
radionuclides
radiopharmaceutical
radiopharmaceutical imaging
single
stability
stable
stable compound
tc
therapeutic
therapeutic compounds
transition
transition metal
transition metals
vitro
vivo
yields
105
109
186
188
99m
agents
aminato
applications
arsine
charged
complexed
complexes
compounds
containing
contrast
contrast agent
contrast agents
derived
design
diagnostic
diagnostic radiopharmaceutical
disclosed
exhibit
form
form stable
formed
functionality
imaging
imaging agent
imaging agents
ligands
metal
metals
mn
moiety
mri
multifunctional
multifunctional ligand
neutral
paramagnetic
pd
phosphine
phosphinimine
phosphinimines
potential
radionuclides
radiopharmaceutical
radiopharmaceutical imaging
single
stability
stable
stable compound
tc
therapeutic
therapeutic compounds
transition
transition metal
transition metals
vitro
vivo
yields